The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective

The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective

Background: The etiology of benign prostatic hyperplasia and prostate cancer are unknown, with ageing being the greatness risk factor. Methods: This new perspective evaluates the available interdisciplinary evidence regarding prostate ageing in terms of the cell biology of regulation and homeostasis...

Full description

Bibliographic Details
Main Author:	Teow J. Phua
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Medicines
Subjects:	benign prostatic hyperplasia prostate cancer testosterone aging vascular aging inflamm-aging amyloidosis
Online Access:	https://www.mdpi.com/2305-6320/8/6/30

Similar Items

Correlation between prostate size and age of patients evaluated for symptomatic benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2020-01-01)

Review of the role of pyroptosis in benign prostatic hyperplasia in old males
by: CHEN Zixuan, et al.
Published: (2023-12-01)

EPIDEMIOLOGY OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: P I Chumakov, et al.
Published: (2018-12-01)

The Effects of 8-Week Endurance Training on Prostatic Autophagy and Benign Prostatic Hyperplasia of Rats
by: Dong-Won Lee, et al.
Published: (2019-08-01)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
by: Ida Bagus O.W. Putra, et al.
Published: (2016-06-01)

A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia
by: Xiaokaiti Naiyila, et al.
Published: (2023-02-01)

Exploring the Role of Testosterone Replacement Therapy in Benign Prostatic Hyperplasia and Prostate Cancer: A Review of Safety
by: André Rizzuti, et al.
Published: (2022-02-01)

Relationships Between American Urological Association Symptom Index, Prostate Volume, and Disease-Specific Quality of Life Question in Patients with Benign Prostatic Hyperplasia
by: Chia-Chu Liu, et al.
Published: (2004-06-01)

Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging
by: Dehong Cao, et al.
Published: (2022-03-01)

Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
by: D Gnyawali, et al.
Published: (2016-07-01)

Serum levels of interleukin-2 differ between prostate cancer and benign prostatic hyperplasia
by: Otavio T Nobrega, et al.
Published: (2022-05-01)

Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients
by: D.E. Orakwe, et al.
Published: (2017-06-01)

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature
by: Codelia-Anjum AJ, et al.
Published: (2023-10-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)

A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection
by: Yu Wu, et al.
Published: (2017-01-01)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01)

Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
by: Da Silva MHA, et al.
Published: (2019-01-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
by: Jing Zhou, et al.
Published: (2023-01-01)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

Cordycepin Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats via Modulation of AMPK and AKT Activation
by: Abdulmohsin J. Alamoudi, et al.
Published: (2022-08-01)

The concentration of androgens and estrogens in benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2021-02-01)

A review of therapeutic exercise strategies for prostate cancer and benign prostate hyperplasia
by: Jin Hwan Yoon
Published: (2020-03-01)

Is opium addiction a risk factor for benign prostatic hyperplasia?
by: Amin Abolhasani Foroughi, et al.
Published: (2023-03-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: N. B. Tabynbaev, et al.
Published: (2017-05-01)

Cadmium Concentration and Metallothionein Expression in Prostate Cancer and Benign Prostatic Hyperplasia of Humans
by: Jane-Dar Lee, et al.
Published: (2009-07-01)

THE FACTORS ASSOCIATED WITH THE INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA
by: sukron sukron
Published: (2022-07-01)

Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia
by: Mohamed Shaker, et al.
Published: (2016-09-01)

Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients
by: Levent Ozcan, et al.
Published: (2017-03-01)

The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
by: Saheed Oluwasina Oseni, et al.
Published: (2023-06-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

Frequency of common complications during treatment of patients with benign prostate hyperplasia
by: Kričković Zoran, et al.
Published: (2020-01-01)

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization
by: Matthias Boschheidgen, et al.
Published: (2023-03-01)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
by: Oka AAG, et al.
Published: (2019-04-01)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
by: Weronika Ratajczak, et al.
Published: (2022-01-01)

The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
by: Konstantinos Stamatiou
Published: (2018-03-01)

Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators
by: Hanna Andrusewicz, et al.
Published: (2011-10-01)

Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer
by: Purandar Sarkar, et al.
Published: (2022-07-01)

An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy
by: Aditya Srinivasan, et al.
Published: (2020-10-01)

Outcome of Surgery for Benign Prostatic Hyperplasia-Is It Predictable?
by: Suhani, et al.
Published: (2013-12-01)